EX-23.1 2 titanpharma_ex23-1.htm EXHIBIT 23.1

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-1 (File Nos. 333- 226841, 333-233722, 333-249550, 333-251187, 333-252482 and 333-262614), Form S-3 (File Nos. 333-230742 and 333-221126) and Form S-8 (File Nos. 333-171181 and 333-207950) of Titan Pharmaceuticals, Inc. of our report dated March 31, 2023, which includes an explanatory paragraph relating to the Company’s ability to continue as a going concern, relating to the financial statements of Titan Pharmaceuticals, Inc., which appears in this Form 10-K.

/s/ WithumSmith+Brown, PC |
San Francisco, California |
March 31, 2023 |